정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 856 | Recruiting | Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial | Coronavirus | Biological: Plasma exchange Drug: Standar medical treatmen |
Phase 2 | Fundacion Clinic per a la Recerca Biomedica | OTHER | 116 | All | 18 Years ~ 80 Years | Hospital Clinic i Provincial de Barcelona, Barcelona, Spain |
| 855 | Completed | Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients | Safety and Efficacy | Biological: Convalescent anti-SARS-CoV-2 MBT plasma Other: Control Group |
Phase 2 | Fundacion FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promocion de la Salud y la Ciencia, Germans Trias i Pujol Hospital, IrsiCaixa, Banc de Sang i Teixits, Grifols Biologicals, LLC | OTHER | 384 | All | 50 Years | Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain Hospital Sant Bernabe (Hospital de Berga), Berga, Barcelona, Spain CUAP Manresa (Planta 0 del CAP Bages), Manresa, Barcelona, Spain Hospital Universitari de Bellvitge, Barcelona, Spain |
| 854 | Completed | Plasma Therapy of COVID-19 in Severely Ill Patients | SARS-CoV-2 Infection | Biological: Convalescent Plasma (anti-SARS-CoV-2 plasma) Biological: Non-convalescent Plasma (control plasma) |
Phase 2 | Max O'Donnell, New York Blood Center, Amazon.com, Inc. | OTHER | 223 | All | 18 Years | Columbia University Irving Medical Center/NYP, New York, New York, United States Hospital Federal dos Servidores do Estado, Rio De Janeiro, Brazil Hospital Geral de Nova Iguacu, Rio De Janeiro, Brazil Instituto Nacional de Infectologia Evandro Chagas, Rio De Janeiro, Brazil |
| 853 | Recruiting | plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients | Covid-19 Pneumonia | Biological: immune plasma | Phase 2 | Azienda USL Toscana Nord Ovest | OTHER | 50 | All | 18 Years | Ospedale delle Apuane, Massa, Toscana, Italy |
| 852 | Active, not recruiting | Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19) | SARS-CoV-2 | Biological: Vaccinated with polio vaccine (IPV) | Phase 4 | E-MO Biology Inc | INDUSTRY | 300 | All | 18 Years ~ 80 Years | Rac Ii Md, National City, California, United States |
| 851 | Completed | Polyvalent Immunoglobulin in COVID-19 Related ARds | COVID-19 | Drug: Human immunoglobulin Drug: Placebo |
Phase 3 | Centre Hospitalier St Anne, Groupe Hospitalier Universitaire Paris psychiatrie & neurosciences, Laboratoire francais de Fractionnement et de Biotechnologies | OTHER | 146 | All | 18 Years | CHU Sud Amiens, Amiens, France CHU Angers, Angers, France Service de reanimation polyvalente, rond point de Girac, Angouleme, France CH Victor Dupouy, Argenteuil, France CH Aulnay, Aulnay-sous-Bois, France Centre hospitalier de Bethune, Beuvry, France Hopital Avicenne, Bobigny, France CH Chalons en champagne, Chalons en champagne, France CH-Nord-Ardennes, Charleville-Mezieres, France Hopital d'instruction des armees Percy, Clamart, France Centre Hospitalier de Dieppe, Dieppe, France Hopital Raymond Poincare, Garches, France CHU de Grenoble, Grenoble, France Grand hopital de l'est Francilien - site de Jossigny, Jossigny, France Hopital Robert Boulin, Libourne, France Pole de Medecine intensive/reanimation Hopital Salengro, CHRU de Lille, Lille, France Groupement Hospitalier Edouar Herriot, Lyon, France Hopital de la Croix Rousse Novembre 2019, Lyon, France Hopital Jacques Cartier, Massy, France Hopital Jacques Monod, Montivilliers, France Service de Medecine Intensive-Reanimation, CHU, Nantes, France CHR Orleans, Orleans, France Centre Hospitalier Sainte-Anne, Paris, France CHU Lariboisiere, Paris, France CHU Pitie Salpetriere Service de reanimation chirurgicale, Paris, France CHU Saint Antoine, Paris, France Fondation ophtalmologique Rotschild, Paris, France Hopital Paris Saint-Joseph, Paris, France Hopital Pitie Salpetriere, Paris, France Institut Mutualiste Montsouris, Paris, France CHU Poitiers, Poitiers, France CHU Robert Debre, Reims, France CH Poissy, Saint-Germain-en-Laye, France Groupe hospitalier Saint Vincent, Strasbourg, France Hopital de Hautepierre, Strasbourg, France Hopital de Tarbes, Tarbes, France Hopital Nord Franche-Comte, Trevenans, France CH Valenciennes, Valenciennes, France Chu Nancy - Brabois, Vandœuvre-les-Nancy, France Hopital de Vannes, Vannes, France Institut Gustave Roussy, Villejuif, France CH Etampes, Etampes, France |
| 850 | Recruiting | Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19) | Acute Respiratory Distress Syndrome | Drug: CUROSURF® (poractant alfa) | Phase 2 | Chiesi Farmaceutici S.p.A. | INDUSTRY | 70 | All | 18 Years ~ 80 Years | Henry Ford Health System, Detroit, Michigan, United States Chiesi site # 14, Bologna, Italy Chiesi site #13, Modena, Italy UCLH and UCL 250 Euston Road, London, United Kingdom Chiesi site #4, London, United Kingdom Chiesi site # 12, Southampton, United Kingdom |